CREDIT SUISSE AG/ - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$545,815
-37.2%
42,910
-30.5%
0.00%0.0%
Q2 2023$868,975
+15.3%
61,717
+26.6%
0.00%0.0%
Q1 2023$753,388
+28.6%
48,763
+36.5%
0.00%0.0%
Q4 2022$585,648
-11.0%
35,732
+0.4%
0.00%0.0%
Q3 2022$658,000
+41.2%
35,573
+0.6%
0.00%
Q2 2022$466,000
+37.5%
35,346
-3.4%
0.00%
Q1 2022$339,000
-0.6%
36,573
+4.6%
0.00%
Q4 2021$341,000
-71.0%
34,975
+1.2%
0.00%
-100.0%
Q3 2021$1,176,000
-0.3%
34,571
+7.3%
0.00%0.0%
Q2 2021$1,179,000
-9.1%
32,218
+11.3%
0.00%0.0%
Q1 2021$1,297,000
-68.0%
28,951
-59.2%
0.00%
-50.0%
Q4 2020$4,053,000
+27.7%
71,008
+14.7%
0.00%0.0%
Q3 2020$3,175,000
-27.6%
61,884
-15.7%
0.00%
-33.3%
Q2 2020$4,385,000
+422.6%
73,421
+260.3%
0.00%
+200.0%
Q1 2020$839,000
-55.0%
20,376
-31.9%
0.00%0.0%
Q4 2019$1,864,000
+283.5%
29,942
+109.3%
0.00%
Q3 2019$486,000
+111.3%
14,307
+144.0%
0.00%
Q2 2018$230,0005,8630.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$72,236,00020.73%
SV Health Investors, LLC 449,951$26,871,00018.64%
Redmile Group, LLC 4,978,941$297,342,0005.49%
Sunesis Advisors, LLC 96,299$5,751,0005.29%
Eversept Partners, LP 418,652$25,001,8973.43%
Opaleye Management Inc. 222,000$13,081,0002.64%
Avoro Capital Advisors LLC 1,860,000$111,079,0002.20%
SPHERA FUNDS MANAGEMENT LTD. 282,965$16,899,0001.59%
SECTORAL ASSET MANAGEMENT INC 224,359$13,399,0001.23%
Artal Group S.A. 650,000$38,818,0001.09%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders